Viewing Study NCT06976203


Ignite Creation Date: 2025-12-24 @ 7:22 PM
Ignite Modification Date: 2026-01-01 @ 5:34 PM
Study NCT ID: NCT06976203
Status: RECRUITING
Last Update Posted: 2025-12-23
First Post: 2025-05-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
Sponsor: Bristol-Myers Squibb
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: CN012-0052
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators